Severe Hb H Disease Caused by Hb Zürich-Albisrieden ( HBA1 : c.178G>C): Another Case Report.
Autorzy:
Wu SM; Prenatal Diagnosis Center, Affiliated Dongguan Hospital, Southern Medical University (Dongguan People's Hospital), Dongguan, Guangdong Province, People's Republic of China. HuangSR; Prenatal Diagnosis Center, Affiliated Dongguan Hospital, Southern Medical University (Dongguan People's Hospital), Dongguan, Guangdong Province, People's Republic of China. Li C; Prenatal Diagnosis Center, Affiliated Dongguan Hospital, Southern Medical University (Dongguan People's Hospital), Dongguan, Guangdong Province, People's Republic of China. Chen GL; Prenatal Diagnostic Center, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, Guangdong Province, People's Republic of China. Li DZ; Prenatal Diagnostic Center, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, Guangdong Province, People's Republic of China.
Pokaż więcej
Źródło:
Hemoglobin [Hemoglobin] 2022 Nov; Vol. 46 (6), pp. 341-343. Date of Electronic Publication: 2023 Feb 23.
Hb Wanjiang: A New β-Globin Chain Variant with Two Amino Acid Substitutions ( HBB : c.255_264delinsTTTTTCTCAG).
Autorzy:
Wu SM; Prenatal Diagnosis Center, Affiliated Dongguan Hospital, Southern Medical University (Dongguan People's Hospital), Dongguan, People's Republic of China. Jiang F; Prenatal Diagnostic Center, Guangzhou Women and Children's Medical Center, Guangzhou, People's Republic of China. Li C; Prenatal Diagnosis Center, Affiliated Dongguan Hospital, Southern Medical University (Dongguan People's Hospital), Dongguan, People's Republic of China. Guo ZT; Clinical Laboratory, Affiliated Dongguan Hospital, Southern Medical University (Dongguan People's Hospital), Dongguan, People's Republic of China. HuangSR; Department of Obstetrics and Gynecology, Affiliated Dongguan Hospital, Southern Medical University (Dongguan People's Hospital), Dongguan, People's Republic of China. Li DZ; Prenatal Diagnostic Center, Guangzhou Women and Children's Medical Center, Guangzhou, People's Republic of China.
Pokaż więcej
Źródło:
Hemoglobin [Hemoglobin] 2022 Mar; Vol. 46 (2), pp. 129-131. Date of Electronic Publication: 2022 Aug 11.
Development of the Heterodyne Laser Encoder System for the X-Y Positioning Stage.
Autorzy:
Chang CP; Department of Mechanical and Energy Engineering, National Chiayi University, Chiayi 600, Taiwan. Tu TC; Department of Mechanical and Energy Engineering, National Chiayi University, Chiayi 600, Taiwan. HuangSR; Department of Mechanical and Energy Engineering, National Chiayi University, Chiayi 600, Taiwan. Wang YC; Department of Mechanical Engineering, National Yunlin University of Science and Technology, Yunlin 640, Taiwan. Chang SC; Department of Mechanical Engineering, National Yunlin University of Science and Technology, Yunlin 640, Taiwan.
Pokaż więcej
Źródło:
Sensors (Basel, Switzerland) [Sensors (Basel)] 2021 Aug 27; Vol. 21 (17). Date of Electronic Publication: 2021 Aug 27.
Benchmarking of eight recurrent neural network variants for breath phase and adventitious sound detection on a self-developed open-access lung sound database-HF_Lung_V1.
Autorzy:
Hsu FS; Graduate Institute of Biomedical Electronics and Bioinformatics, National Taiwan University, Taipei, Taiwan.; Department of Critical Care Medicine, Far Eastern Memorial Hospital, New Taipei, Taiwan.; Heroic Faith Medical Science Co., Ltd., Taipei, Taiwan. HuangSR; Heroic Faith Medical Science Co., Ltd., Taipei, Taiwan. Huang CW; Avalanche Computing Inc., Taipei, Taiwan. Huang CJ; Joint Research Center for Artificial Intelligence Technology and All Vista Healthcare, National Taiwan University, Taipei, Taiwan. Cheng YR; Heroic Faith Medical Science Co., Ltd., Taipei, Taiwan.; Department of Life Science, College of Life Science, National Taiwan University, Taipei, Taiwan.; Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan. Chen CC; Avalanche Computing Inc., Taipei, Taiwan. Hsiao J; HCC Healthcare Group, New Taipei, Taiwan. Chen CW; Department of Critical Care Medicine, Far Eastern Memorial Hospital, New Taipei, Taiwan. Chen LC; Research Center for Information Technology Innovation, Academia Sinica, Taipei, Taiwan. Lai YC; Heroic Faith Medical Science Co., Ltd., Taipei, Taiwan. Hsu BF; Heroic Faith Medical Science Co., Ltd., Taipei, Taiwan. Lin NJ; Heroic Faith Medical Science Co., Ltd., Taipei, Taiwan.; Division of Pulmonary Medicine, Far Eastern Memorial Hospital, New Taipei, Taiwan. Tsai WL; Heroic Faith Medical Science Co., Ltd., Taipei, Taiwan. Wu YL; Heroic Faith Medical Science Co., Ltd., Taipei, Taiwan. Tseng TL; Heroic Faith Medical Science Co., Ltd., Taipei, Taiwan. Tseng CT; Heroic Faith Medical Science Co., Ltd., Taipei, Taiwan. Chen YT; Heroic Faith Medical Science Co., Ltd., Taipei, Taiwan. Lai F; Graduate Institute of Biomedical Electronics and Bioinformatics, National Taiwan University, Taipei, Taiwan.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2021 Jul 01; Vol. 16 (7), pp. e0254134. Date of Electronic Publication: 2021 Jul 01 (Print Publication: 2021).
A multicenter, randomized, open-label, controlled trial to evaluate the efficacy and tolerability of hydroxychloroquine and a retrospective study in adult patients with mild to moderate coronavirus disease 2019 (COVID-19).
Autorzy:
Chen CP; Department of Infectious Diseases, Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan, Taiwan.; Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan. Lin YC; Department of Infectious Diseases, Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan, Taiwan.; Graduate Institute of Clinical Medicine, Taipei Medical University, Taipei, Taiwan. Chen TC; Department of Internal Medicine, Taichung Hospital, Ministry of Health and Welfare, Taichung, Taiwan. Tseng TY; Department of Internal Medicine, Taichung Hospital, Ministry of Health and Welfare, Taichung, Taiwan. Wong HL; Department of Internal Medicine, Keelung Hospital, Ministry of Health and Welfare, Keelung City, Taiwan. Kuo CY; Department of Internal Medicine, Pingtung Hospital, Ministry of Health and Welfare, Pingtung, Taiwan. Lin WP; Department of Internal Medicine, Taipei Hospital, Ministry of Health and Welfare, New Taipei City, Taiwan. HuangSR; Department of Internal Medicine, Miaoli General Hospital, Ministry of Health and Welfare, Miaoli, Taiwan. Wang WY; Department of Internal Medicine, Feng Yuan Hospital, Ministry of Health and Welfare, Taichung, Taiwan. Liao JH; Department of Internal Medicine, Nantou Hospital, Ministry of Health and Welfare, Nantou, Taiwan. Liao CS; Department of Internal Medicine, Chia Yi Hospital, Ministry of Health and Welfare, Chiayi, Taiwan. Hung YP; Department of Internal Medicine, Tainan Hospital, Ministry of Health and Welfare, Tainan City, Taiwan. Lin TH; Department of Internal Medicine, Chang Hua Hospital, Ministry of Health and Welfare, Changhua, Taiwan. Chang TY; Department of Internal Medicine, Chang Hua Hospital, Ministry of Health and Welfare, Changhua, Taiwan. Hsiao CF; Institute of Population Health Sciences, National Health Research Institutes, Zhunan, Taiwan. Huang YW; Department of Internal Medicine, Chang Hua Hospital, Ministry of Health and Welfare, Changhua, Taiwan.; Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan. Chung WS; Department of Internal Medicine, Taichung Hospital, Ministry of Health and Welfare, Taichung, Taiwan.; Department of Health Service Administration, China Medical University, Taichung, Taiwan.; Department of Healthcare Administration, Central Taiwan University of Science and Technology, Taichung, Taiwan. Cheng CY; Department of Infectious Diseases, Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan, Taiwan.; School of Public Health, National Yang-Ming University, Taipei, Taiwan. Cheng SH; Department of Infectious Diseases, Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan, Taiwan.; School of Public Health, Taipei Medical University, Taipei, Taiwan.
Effects of inflammatory factors including plasma tumor necrosis factor-α in the clinical treatment of acute respiratory distress syndrome.
Autorzy:
HuangSR; Department of Intensive Care Unit, The Affiliated Qingdao Municipal Hospital of Qingdao University, Qingdao, Shandong 266071, P.R. China.; Department of Intensive Care Unit, The Affiliated Hospital of Jining Medical University, Jining, Shandong 272029, P.R. China. Ma AY; Department of Intensive Care Unit, The Affiliated Hospital of Jining Medical University, Jining, Shandong 272029, P.R. China. Liu Y; Department of Intensive Care Unit, The Affiliated Qingdao Municipal Hospital of Qingdao University, Qingdao, Shandong 266071, P.R. China. Qu Y; Department of Intensive Care Unit, The Affiliated Qingdao Municipal Hospital of Qingdao University, Qingdao, Shandong 266071, P.R. China.
Pokaż więcej
Źródło:
Oncology letters [Oncol Lett] 2017 Jun; Vol. 13 (6), pp. 5016-5020. Date of Electronic Publication: 2017 Apr 25.
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
